Yaron S. Rabinowitz, MD is Chief of Ophthalmology at Cedars-Sinai and an ophthalmologist specializing in the cornea, refractive surgery (LASIK) and hereditary eye diseases. He is a clinical professor of ophthalmology and pediatrics at the David Geffen School of Medicine at University of California, Los Angeles (UCLA).
In 1990, Dr. Rabinowitz founded the Cornea-Genetic Genetic Eye Medical Clinic at Cedars-Sinai. A major focus of the clinic was on genetic eye diseases and pediatric corneal transplantation.
An internationally recognized expert on keratoconus and pediatric corneal transplantation, Dr. Rabinowitz has received research funding from the National Eye Institute of Health. Recently, he was appointed to the National Eye Institute's five-year program planning committee panel for corneal diseases. He is a co-investigator in the Federal Drug Administration (FDA)-sponsored VISX® hyperopic astigmatism clinical trial and the Autonomous Technologies LASIK clinical trial.
Dr. Rabinowitz is the author of a textbook on corneal topography and more than 80 scientific journal articles and abstracts, and he has given over 100 lectures in more than a dozen countries on genetic diseases of the eye. He is also the inventor of a computer program used worldwide for screening patients before refractive surgery. Dr. Rabinowitz has performed several thousand refractive surgical procedures since completing his fellowship in 1989. He was one of the first surgeons in the United States to perform the new, improved "down-up" LASIK technique.
He received fellowship training in cornea and refractive surgery at the Doheny Eye Institute at University of Southern California and in ophthalmic and molecular genetics at Wilmer Institute at Johns Hopkins University, where he was a Fight for Sight, Research to Prevent Blindness Scholar.
